• 1
    Tufts Center for the Study of Drug Development Backgrounder: How New Drugs Move Through the Development and Approval Process. Boston, 2001. []. Accessed 18 October 2006.
  • 2
    Innovation—Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. US Department of Health and Human Services, Food and Drug Administration, 2004. []. Accessed 18 October 2006.
  • 3
    Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:117383.
  • 4
    Ancel P, Livinec F, Larroque B, Marret S, Arnaud C, Pierrat V, et al. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE Cohort Study. Pediatrics 2006;117:82835.
  • 5
    Lieman JM, Brumfield CG, Carlo W, Ramsey PS. Preterm premature rupture of membranes: is there an optimal gestational age for delivery? Obstet Gynecol 2005;105:1217.
  • 6
    Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor. Ultrasound Obstet Gynecol 2006;27:36872.
  • 7
    The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta adrenergic agonist ritodrine. N Engl J Med 1992;327:30812.
  • 8
    Goodwin TM, Randall H, Perry K, Menard MK, Bauer C, Shangold G, et al. A report on infant outcomes at 6 and 12 months after the use of atosiban in the management of preterm labor. American College of Obstetricians and Gynecologists, New Orleans, LA, USA, May 1998.
  • 9
    Houtzager BA, Hogendoorn SM, Papatsonis DN, Samsom JF, Van Geijn HP, Bleker OP, et al. Long-term follow up of children exposed in utero to nifedipine or ritodrine for the management of preterm labour. BJOG 2006;113:32431.
  • 10
    Smith GN, Walker MC, Ohlsson A, et al. The use of transdermal nitroglycerin for preterm labor. Annual Meeting of the Society for Gynecologic Investigation, Toronto, Canada, March 22–25, 2006.
  • 11
    Milne CP. The Food and Drug Modernization Act and the Food and Drug Administration: metamorphosis or makeover? Drug Information Journal 2000;34:68192.